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R A P I D C O M M U N I C AT I O N

Excited delirium: Consideration of selected
medical and psychiatric issues
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Abstract: Excited delirium, sometimes referred to as agitated or excited delirium, is the label
assigned to the state of acute behavioral disinhibition manifested in a cluster of behaviors that
may include bizarreness, aggressiveness, agitation, ranting, hyperactivity, paranoia, panic,
violence, public disturbance, surprising physical strength, profuse sweating due to hyperthermia, respiratory arrest, and death. Excited delirium is reported to result from substance
intoxication, psychiatric illness, alcohol withdrawal, head trauma, or a combination of these.
This communication reviews the history of the origins of excited delirium, selected research
related to its causes, symptoms, management, and the links noted between it and selected medical
and psychiatric conditions. Excited delirium involves behavioral and physical symptoms that
are also observed in medical and psychiatric conditions such as rhabdomyolysis, neuroleptic
malignant syndrome, and catatonia. A useful contribution of this communication is that it links
the state of excited delirium to conditions for which there are known and effective medical and
psychiatric interventions.
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The state referred to as agitated or excited delirium has its origins in the mid 1970s
when cocaine intoxication was reported to result in cocaine psychoses.1 Aspects of these
psychoses and more severe and lethal physical symptoms such as acute toxic psychosis, seizures, coma, respiratory collapse, and death were also observed in individuals
attempting to smuggle packets of cocaine that leaked or broke in their bodies.2 Excited
delirium was explicitly described in 1985 as a state resulting from cocaine intoxication
involving acute intense paranoia, bizarreness, violence, surprising physical strength,
hyperthermia, and fatal respiratory collapse within minutes or hours after restraint.3
An individual hospitalized in an excited and delirious state might meet the criteria for
substance intoxication delirium and mania. Substance intoxication delirium involves
disorientation, disruption of awareness, inability to attend, confusion, perceptual difﬁculties, and inappropriate responses to changing situations. The excitement can be
seen as similar to the excitement of the acute phase of bipolar mania with grandiosity,
distractibility and psychomotor agitation.4
Excited delirium has been acknowledged as being among several acute excited
states such as catatonic excitement or delirious mania.5
In this regard, the behavioral excitement aspect of excited delirium is quite
similar to the excitement seen in catatonic excitement. Patients’ behavior in catatonic
excitement may be “stereotypic with sudden outbursts of talking, singing, dancing,
and tearing at their clothes. They become irritable and may damage objects or injure
hospital staff ”.6 Taylor6 observes that catatonic excitement is difﬁcult to differentiate
from delirious mania. According to Fink,7 delirious mania is seen in the emergence
of severe “excitement, grandiosity, emotional lability, delusions, and insomnia
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characteristic of mania, and the disorientation and altered
consciousness characteristic of delirium. Almost all patients
exhibited signs of catatonia.” Catatonia signs may involve
physical immobility seen as cataleptic or stuporousness,
excessive purposeless physical activity, serious negativism
or mutism, idiosyncratic voluntary movements, echolalia
involving the repetition of words or phrases, or ecopraxia
involving repetitive copying of another person’s movements.4
The most likely catatonia signs manifested by persons in a
state of excited delirium would be excitement manifested
in excessive purposeless physical activity, idiosyncratic
voluntary movements, echolalia and/or echopraxia.

Issues regarding excited delirium
Excited delirium has gained public notice because it has so
often been among the post-mortem explanations offered by
medical examiners in the deaths of individuals during the
process of being restrained by law enforcement to be taken
into custody or while being held in custody.8–16 Studies
by medical examiners have focused on determining the
causes of the deaths of individuals described as being in a
state of excited delirium prior to and after being restrained
and whether or how restraint may have played a role in the
deaths of these individuals.17–19 The prevalence of agitated
or excited delirium is uncertain and studies have tended to
focus on deceased victims.11 An informative result of the
studies is the ﬁnding that excited delirium is not only due
to substance intoxication but also to psychiatric illness,
alcohol withdrawal, head trauma or a combination of these
conditions.8–11,14 The case presented below is an example
of the context within which many persons in a state of
excited delirium are encountered by law enforcement and
emergency services.

A case of untreated excited
delirium and sudden death
This case was abstracted from selected news articles by
Babstock20–24 on a coroner’s inquest into the death of a man
while police were restraining him in order for him to be rehospitalized. The 34-year-old man had a history of major
psychiatric illness which was diagnosed as bipolar disorder
when he was 18 years old. It is reported that treatment was
occasionally affected by his use of marijuana, hashish, LSD,
and amphetamines. During the several years before his death,
this patient was seen every few weeks by a psychiatrist who
described him as doing well or, at times, as hypomanic or
depressed. He was an unpredictable patient who could not
be depended upon to take his prescribed medication or avoid
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using marijuana. Hospitalization was required for a psychotic
episode during which he had delusions of persecution and
was ranting about religious topics. He was restricted to a
locked unit for patients considered dangerous to self and
others for two days. By the third day of hospitalization, he
was transferred to an open unit on the basis of his improved
demeanor and compliance with treatment. He was not
permitted to leave the open unit–not even for a cigarette.
Later on the same day that he had been transferred, at about
9:00 PM, he walked off the unit telling a psychiatric attendant
pursuing him that he was going for a cigarette. At 9:30 PM,
it was determined that he had left the hospital and the police
were notiﬁed. He had apparently gotten a cab and requested to
be taken to several places. The driver stopped the cab after the
man grabbed the steering wheel. The patient left the cab and
made his way to a lounge. At the lounge, he was reported to
be talking to mirrors, asking questions and walking back and
forth in front of the bar. His behavior caused the proprietor to
call for police assistance. When the police arrived to return
him to the hospital, he refused and attempted to avoid being
restrained. He was described as sweating, breathing heavily,
and with dilated pupils. His attempt to avoid restraint resulted
in smashed tables and injury of a police ofﬁcer. The police
used pepper spray and Taser in attempting to restrain him.
It took four ofﬁcers to subdue him and almost immediately
after being restrained he stopped breathing. Cardiopulmonary
resuscitation was initiated and a call was made for emergency medical assistance. Attempts to resuscitate him were
unsuccessful. During the coroner’s inquest it was noted that
he was obese, had asthma, an enlarged heart, and had eight
Taser wounds. Ultimately, an expert’s testimony attributed
his death to excited delirium. His history of substance misuse
and psychiatric illness are two possible antecedents to his
state of excited delirium. It is noteworthy that this case is
similar in its outcome to many others in that the client died
while being restrained to be taken into custody (eg, Bast15).

A diagnostic problem
Concern has been expressed that although the state of excited
delirium is given as an explanation for in-custody deaths, it is
currently not a recognized medical or psychiatric diagnosis
according to either the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IVTR) of the American Psychiatric
Association4 or the International Classiﬁcation of Diseases
(ICD-9) of the World Health Organization.25–27 Yet it is
important to note that a lack of recognition does not negate
the seriousness of the behavioral and physical symptoms
referred to as excited delirium. It is noteworthy that one
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study found that only 18 of 214 individuals identiﬁed as
manifesting excited delirium died when restrained and taken
into custody.12 Unfortunately, the study did not report if or
whether the survivors were diagnosed or treated.

Rhabdomyolysis, neuroleptic
malignant syndrome, and catatonia
Cocaine-intoxicated individuals in a state of excited
delirium have been reported to have cocaine blood level
concentrations ten times lower than individuals who died
of cocaine overdoses without excited delirium. The excited
delirium and lower cocaine levels is explained as due to
modiﬁcations of dopamine processing resulting from habitual
cocaine use.18 Studies have noted that survivors of cocaine
intoxication with excited delirium have also been reported
to develop rhabdomyolysis which results in skeletal muscle
breakdown and leakage of muscle substance into the circulatory system that has clinical similarities to neuroleptic
malignant syndrome (NMS).17,18,28–30 Ruttenber and colleagues17 maintain that excited delirium and cocaine-induced
rhabdomyolysis are aspects of the same syndrome that is
likely due to chronic cocaine use. The issue of the clinical
similarities between cocaine induced rhabdomyolysis and
NMS points to the speculation of whether cocaine rhabdomyolysis is a form of NMS.29,31 Neuroleptic malignant syndrome
is manifested in severe muscle rigidity, fever, cognitive
confusion, elevated creatinine phosphokinase and/or white
blood count levels allegedly related to the administration of
neuroleptic medications.4,32 A 1991 study found that cocaine
abusers treated with neuroleptics developed NMS whereas
nonabusers did not.33 Khaldarov34 successfully treated a
patient, with a history of cocaine abuse and recent treatment with ﬂuphenazine, with lorazepam on the basis of the
assumption that cocaine-associated rhabdomyolysis with
hyperthermia and NMS are the same condition.
Lopez-Canino and Francis,35 in their review of the
literature on drug-induced catatonia from the study of phencyclidine intoxication by McCarron and colleagues,36 also
noted an association between rhabdomyolysis and catatonia.
Other studies have reported an association between psychosis
(eg, mania and schizophrenia) involving overactivity, catatonia and rhabdomyolysis.37–39 In sum, the literature appears
to suggest some association between the state of excited
delirium, rhabdomyolysis, NMS and even catatonia. Studies
have also noted that NMS and catatonia seem to be different
aspects of the same syndrome (cf, Fink;40 Carroll;41 Koch and
colleagues42). Petrides and colleagues43 propose that NMS
itself is a form of catatonia whose features are similar to those
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of malignant catatonia and that they may both beneﬁt from
similar treatment.
The association researchers have established between
excited delirium and the potentially life-threatening syndromes of rhabdomyolysis, NMS, and catatonia give impetus
to the need for critical emergency medical interventions when
encountering a person thought to be in a state of excited
delirium.

A case of treated excited delirium
Petrides and colleagues43 report on treating a patient “… in a
state of excited delirium following intrethecal administration of
an analgesic for chronic pain” (for the original report see Levin
and colleagues45). Symptoms included purposeless agitation,
stiffness, serious negativism or mutism, and staring. Creatine
phosphokinase level remained elevated. His temperature was
quite high and he required physical restraint. There was no
beneﬁt from intravenous haloperidol, lorazepam, or midazolam.
The delirium remained refractory and the patient required intensive care with intubation and ventilation. By the 18th day of
hospitalization it was determined that electroconvulsive therapy
(ECT) should be initiated and ﬁve treatments were administered
during thee days. On the 21st day of hospitalization, after a
ﬁnal ECT, he was able to interact with his wife. He improved
and had no memory of his illness and was able to return to
part-time work. After three months he was regarded as fully
recovered (cf, Levin and colleagues45). Petrides and colleagues43
retrospectively reported this patient as an example of someone
manifesting “atypical catatonic features”. Interestingly, in the
original case report there was no discussion of catatonia and
the administration of ECT appears to have been initiated to
treat the delirium (cf, Strömgren;45 Fink46). This is noteworthy
in view of the fact that the DSM-IVTR guidelines for catatonia
due to a medical condition would not apply to an individual
manifesting a delirium to ensure that the medical source of
the delirium is resolved.4 The success of the intervention in
this instance suggests that even a delirium due to a medical
condition refractory to other interventions may beneﬁt from
those speciﬁcally designated for catatonia such as high doses
of lorazepam (12 to 20 mg/day) or ECT when the lorazepam
is not effective.
There are some similarities between the state of excited
delirium and catatonia that may be best seen in examining
case examples of catatonia when the catatonia involves agitation and excessive physical or motor activity. Below are two
case examples of catatonia in individuals with symptoms of
agitation and excessive physical activity (cases from Ferrell
and Williams47).
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Case examples of catatonia
Case A
This is the case of a 75-year-old woman with a history of
major psychiatric illness, which was diagnosed as schizophrenia when she was in her 20s. She subsequently suffered
a hemorrhagic stroke from an anterior communicating artery
aneurysm in her 20s. Both frontal lobes sustained extensive
destruction and a more severe mental syndrome emerged
after the stroke. Many years of psychiatric hospitalization
resulted. The treatments initiated included 80 ECT treatments, many hours of continuous baths, insulin coma therapy,
various anti-psychotic medicines and assorted psychotropic
drugs, including anticonvulsants. She had severe tardive
dyskinesia. At age 75 an episode of extreme agitation with
catatonic symptoms of constant motor activity, disrobing,
marked negativism, echolalia and echopraxia occurred. Her
creatine kinase value was ⬎2400. Treatment was initiated
by discontinuing her previously prescribed haloperidol and
initiation of lorazepam up to 16 milligrams per day in divided
doses. The catatonic syndrome remitted and did not recur.
Treatment with low dose lorazepam was continued. Antipsychotic medications were not restarted and there was no
return of psychotic symptoms.

Case B
A 74-year-old woman first experienced the onset of
delusional symptoms at age 21. At that time, she was assessed
and attained a full scale IQ of 70. Her symptoms were
diagnosed as indications of schizophrenia. She recovered
from this initial illness and lived a quiet productive life in
the care of her family until age 51. After a “ﬂu-like illness,”
she attempted to return to her assembly-line job where she
was found standing mute and motionless on the line. She
required hospitalization and received institutional care until
her death almost 30 years later. While suffering a severe
neuropsychiatric illness she manifested sustained periods of
social withdrawal, posturing, and muteness. At age 74 she
suffered an episode of severe excitement, agitation, delirium,
sleeplessness and dehydration. The syndrome was life threatening. Results of a magnetic resonance imaging (MRI) study
revealed advanced cerebral atrophy without focal ﬁndings
as had several prior computed tomography (CT) scans. An
electroencephalograph (EEG) was normal. There was a history of prior protracted periods of severe agitation and yelling
as observed at age 74, though less severe. Prior treatment
with medication was marginally successful, including trials
of typical antipsychotic drugs, antidepressants, lithium,
diphenhydramine, chloral hydrate, divalproex sodium,
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methylphenidate, and benzodiazepines. She responded well
to six ECT treatments. After a relapse, she recovered with
12 additional ECT treatments. The catatonia did not recur
with clozapine prophylaxis during the remaining six years
of her life. ECT treatment was regarded as life-saving for
this patient.
In both the untreated and treated cases of excited delirium
the symptoms were unexpected as were the symptoms of
catatonia in the cases discussed above. The serious difference
in the outcomes was the fact that the individuals – one in
a state of excited delirium and two with catatonia – who
were hospitalized were expeditiously diagnosed and treated.
Regarding medical care and excited delirium, Stratton
and colleagues 12 have made the observation “… that
unexpected sudden death when excited delirium victims
are restrained in the out-of-hospital setting is not infrequent
and can be associated with multiple predictable but usually
uncontrollable factors.”

Discussion
It is noteworthy that excited delirium, NMS and catatonia
may result in many physical symptoms that are similar such
as profuse sweating, dehydration, electrolyte imbalance,
fever, tachycardia, hypertension, rapid breathing, and the
possibility of death without proper treatment.9,14,32,48–50
Treatment recommended for excited delirium, NMS and
catatonia are quite similar. Selected aspects of the treatment
approach for excited delirium reported here are based upon
recommendations in Karch and Stephens,10 Petrides and
colleagues43 (cf Levin and colleagues45), and Sztajnkrycer
and Baez.14 Individuals manifesting excited delirium should
be evaluated for their medical needs on an emergency basis.
They should especially receive temperature, oximetry and
cardiac monitoring. Temperature management interventions
should be initiated as necessary. Due to the psychomotor
agitation during the state of excited delirium, treatment with
benzodiazepines, and possibly in high doses is recommended.
Neuroleptics are not recommended due to the possible
adverse inﬂuence on temperature regulation, seizure threshold and arrhythmia. If benzodiazepines are not effective, ECT
should be considered as it was in the excited delirium case
reported by Petrides and colleagues.43
In sum, the association between the state of excited
delirium and the potentially life-threatening syndromes of
rhabdomyolysis, NMS and catatonia give impetus to the need
for critical emergency medical care for persons encountered
in a probable state of excited delirium. Rigorous effort should
be aimed at establishing the best possible understanding of
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relevant medical and psychiatric diagnosis. Correct diagnosis
leads to rational and effective treatment. Research into
understanding and managing excited delirium may receive
considerable beneﬁt from examining the documentation
on the diagnosis and care of persons with rhabdomyolysis,
NMS and catatonia for which there are known and effective
medical and psychiatric interventions.
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